Cannabis and psychosis: more research

A systematic review by 4 medical institutions in Germany found that cannabinoids likely contribute to chronic psychotic events and schizophrenia, especially if taken during adolescence: – the odds of developing psychosis-like events or schizophrenia was 2.88 – and double the risk among teens.